Insider buying
~$90K10K sh @ $8.95
Traded Nov 13 · filed 3 days later
A Legend Biotech director paid $90K out of pocket for Legend Biotech shares. Shares held went up 15% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 12, 2026 · Filed Nov 16, 2026
A Legend Biotech director paid $94K out of pocket for Legend Biotech shares. Shares held went up 18% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$93,750
Shares × reported transaction price
$25K–$100K
+18.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $18.54 on Nov 12, 2026, 11% above its 52-week low and 49% below its high, after a 4% drop over the previous 30 trading days
52-week range $16.65 (Feb 4, 2026) to $36.28 (Jun 2, 2026), 10% of the way up, from 250 adjusted closes. 30 trading days earlier: $19.32 on Oct 1, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
No insider of LEGN had bought shares on the open market before, in filings since 2026
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider buying
Traded Nov 13 · filed 3 days later
A Legend Biotech director paid $90K out of pocket for Legend Biotech shares. Shares held went up 15% with this purchase.
Insider selling
Traded Sep 29 · filed 3 days laterNot reported under a pre-arranged trading plan
A Legend Biotech director sold $259K of Legend Biotech shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Sep 24 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.